Copertina

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shozo Sueda, Yutaka Hayashi, Hiroki Ono, Hikaru Okabe, Tomoki Sakaue, Shuntaro Ikeda
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Cardiology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg
di: Shozo Sueda, et al.
Pubblicazione: (2024)

Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In‐Stent Restenosis
di: Botao Zhao, et al.
Pubblicazione: (2026)

Association Between Handgrip Strength and Mortality of Patients With Coronary Artery Disease: A Meta‐Analysis
di: Meiling Xiao, et al.
Pubblicazione: (2024)

Management of Antithrombotic Therapy in Patients With Coexisting Atrial Fibrillation and Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention Within the Last Year
di: Sebastian König, et al.
Pubblicazione: (2025)

Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery Disease
di: Po‐Hsueh Su, et al.
Pubblicazione: (2025)

Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis
di: Tara Reshadmanesh, et al.
Pubblicazione: (2024)

“A Biomarker‐Based Scoring System to Assess the Presence of Obstructive Coronary Artery Disease in Patients With Myocardial Infarction”
di: María Jesús Espinosa Pascual, et al.
Pubblicazione: (2025)

Incremental Value of Non‐Gated Chest CT Coronary Artery Calcium Score in Predicting Major Adverse Cardiovascular Events by GRACE Score After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
di: Zhaoyuan Xing, et al.
Pubblicazione: (2025)

The Effect of Different Statin‐Based Lipid‐Lowering Strategies on C‐Reactive Protein Levels in Patients With Stable Coronary Artery Disease
di: Zhimin Xue, et al.
Pubblicazione: (2024)

Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention Outcomes
di: Mauricio Rigodanzo Mocha, et al.
Pubblicazione: (2025)

Meta‐Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease
di: Mushood Ahmed, et al.
Pubblicazione: (2024)

Clinical Outcomes of Immediate Versus Staged Revascularization of Nonculprit Arteries in Patients With Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis
di: Farah Yasmin, et al.
Pubblicazione: (2025)

The Potential Role of Baseline FT3/FT4 Ratio as a Prognostic Biomarker for Patients With Ischemic Non‐Obstructive Coronary Artery Disease
di: Feipeng Wu, et al.
Pubblicazione: (2026)

Prevalence and Determinants of Coronary Artery Calcification in Adults With Metabolic Syndrome: A Systematic Review and Meta‐Analysis
di: Aftab Ullah, et al.
Pubblicazione: (2025)

Association Between State‐Wide Cardiac Quality Improvement Program and Costs Following Intervention for Coronary Artery Disease
di: Edwin S. Wong, et al.
Pubblicazione: (2024)

Is There a Need for Sex‐Tailored Lipoprotein(a) Cut‐Off Values for Coronary Artery Disease Risk Stratification?
di: Ece Yurtseven, et al.
Pubblicazione: (2024)

Critique on “Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study”
di: Vishan Das, et al.
Pubblicazione: (2026)

C ‐Reactive Protein–Triglyceride–Glucose Index and Coronary Artery Calcium Progression: A Prospective Cohort Analysis
di: Qing‐Yun Hao, et al.
Pubblicazione: (2026)

Comment on “Epicardial Fat Thickness as a Marker of Coronary Artery Disease in Diabetics: A Single Center Study”
di: Mashal Naveed, et al.
Pubblicazione: (2026)

The Plaque Analysis Classifies the Coronary Artery Disease‐Reporting and Data System (CAD‐RADS) Stenosis and Plaque Burden Categories: Association of the Plaque Features, Fat Attenuation Index, Coronary Computed Tomography Fractional Flow Reserve, and the Combination of Stenosis and Calcification
di: Wenxi Chen, et al.
Pubblicazione: (2024)

Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome
di: Yanming Zhang, et al.
Pubblicazione: (2025)

Sex‐Specific Associations With Abnormal Myocardial Flow Reserve in Non‐Obstructive Coronary Artery Disease: Insights From a Real‐World Cadmium‐Zinc‐Telluride SPECT Study
di: Ya‐Jie Wang, et al.
Pubblicazione: (2026)

Long‐Term Effectiveness of a Stent‐Less Strategy With Drug Coated Balloon in Coronary Artery Disease: 3‐Year Follow‐Up of a Prospective All‐Comers Observational Study
di: Ludovic Meunier, et al.
Pubblicazione: (2025)

A Predictive Nomogram of In‐Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit
di: Wenhui Wang, et al.
Pubblicazione: (2024)

Association Between Orthostatic Hypotension With Coronary Slow Flow in Patients With Chest Pain: A Single Center Experience
di: Lijun Han, et al.
Pubblicazione: (2024)

Stratification of Early Arrhythmic Risk in Patients Admitted for Acute Coronary Syndrome: The Role of the Machine Learning‐Derived “PRAISE Score”
di: Luca Cumitini, et al.
Pubblicazione: (2024)

Persistent Renal Dysfunction After Acute Kidney Injury Among STEMI Patients Undergoing Primary Coronary Intervention: Prevalence and Predictors
di: Shir Frydman, et al.
Pubblicazione: (2024)

LDL‐C and hs‐CRP Jointly Modify the Effect of Lp(a) on 5‐Year Death in Patients With Percutaneous Coronary Intervention
di: Jiawen Li, et al.
Pubblicazione: (2024)

How to Prevent Arrhythmias Following Acute Coronary Syndrome
di: Naoya Kataoka, et al.
Pubblicazione: (2025)

Incorporating Inflammation Biomarker‐Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction in Acute Myocardial Infarction Following Emergency Percutaneous Coronary Intervention
di: Zhuoya Yao, et al.
Pubblicazione: (2024)

Bridging With Low‐Molecular‐Weight Heparin Versus Antiplatelet Therapy in Patients Undergoing Noncardiac Surgery After Percutaneous Coronary Intervention: A Comprehensive Review
di: Syed Javaid Iqbal, et al.
Pubblicazione: (2024)

Reply to “How to Prevent Arrhythmias Following Acute Coronary Syndrome”
di: Luca Cumitini, et al.
Pubblicazione: (2025)

Clopidogrel Versus Aspirin as Monotherapy Following Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome Receiving a Drug‐Eluting Stent: A Systematic Literature Review and Meta‐Analysis
di: Dirk Sibbing, et al.
Pubblicazione: (2024)

Exploring the Link: Marijuana Use Patterns and Their Impact on Coronary Heart Disease Risk
di: Tianwen Wei, et al.
Pubblicazione: (2025)

AsistIAM: Innovating the Acute Coronary Syndrome Approach in Primary Care Settings
di: James S. Díaz, et al.
Pubblicazione: (2026)

The Effect of Age on Improvement in Health‐Related Quality of Life After Percutaneous Coronary Intervention
di: Laura Lappalainen, et al.
Pubblicazione: (2026)

Exome Sequencing Identified Susceptible Genes for High Residual Risks in Early‐Onset Coronary Atherosclerotic Disease
di: Runda Wu, et al.
Pubblicazione: (2024)

What US Cardiology Can Learn From the 2023 ESC Guidelines for the Management of Acute Coronary Syndromes
di: Nanette K. Wenger
Pubblicazione: (2024)

Naples Prognostic Score and Clinical Outcomes After PCI for Acute Coronary Syndrome: A Systematic Review and Meta‐Analysis
di: Yasin Özen, et al.
Pubblicazione: (2025)

Rationale and Design of the PASSIVATE‐CAP Trial: The Preventive Intervention Value of Drug‐Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques
di: Zhongxiu Chen, et al.
Pubblicazione: (2026)